NJ Appeals Court Nixes $2.6M Ruling Against Roche

By Erin Coe

Law360, New York (March 12, 2009, 12:00 AM ET) -- In a boost for Hoffmann-La Roche Inc., a New Jersey appellate court has vacated a judgment that awarded $2.6 million to a man who claimed he had to have surgery to remove his colon after taking the acne treatment Accutane.

The New Jersey Superior Court Appellate Division on Thursday held that a trial court’s restrictions on Roche to present information to the jury on the number of Accutane users as part of its defense constituted “reversible and harmful error” and required the judgment to be scrapped...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles